PowerPoint presentation: “Marketing Practices of the Pharmaceutical Industry”
Southern Collaboration in Research to Impact Prescription of Therapeutics (SCRIPTS) is a project aimed to"help prescribers enhance their ability to evaluate drug related information to improve their prescribing practices and describe proper prescribing practices to improve quality of patient care". It is sponsored by University of Alabama at Birmingham. They developed a very interesting and […]
Xigris (Drotrecogin alfa activated): concerns of serious bleeding and increased death trigger FDA safety review
On February 4th, 2009 the FDA announced an ongoing safety review of Xigris (Drotrecogin alfa [activated]). An introduction from Wikipedia: Drotrecogin alfa (activated) (Xigris, marketed by Eli Lilly and Company) is a recombinant form of human activated protein C ( rhAPC) that has anti-thrombotic, anti-inflammatory, and profibrinolytic properties. Drotrecogin alpha (activated) belongs to the class […]